Ritlecitinib(Litfulo)

Ritlecitinib is an oral, highly selective inhibitor of JAK3/TEC family kinases and a novel targeted immunomodulatory agent.

WhatsApp

To ensure medication safety, consult customer service for free before purchasing. Returns/exchanges are not accepted except for quality issues.

Authentic

Guarantee

Fast Delivery

Privacy

Ritlecitinib Medication Guide

Important Precautions for Ritlecitinib Use

As a selective Janus kinase (JAK) inhibitor, ritlecitinib modulates immune responses mainly by inhibiting the activities of JAK1 and JAK3, providing a···【Read More】
Update: 02 Mar,2026Source: Haiou HealthViews: 69
Dosage and Administration Guidelines for Ritlecitinib

Ritlecitinib is an oral small‑molecule drug belonging to the class of dual JAK3/TEC kinase inhibitors, mainly used for the treatment of autoimmune dis···【Read More】
Update: 02 Mar,2026Source: Haiou HealthViews: 70